基金产品审批或启动逆周期调节！主动控制规模 不追求爆款

Core Viewpoint - The regulatory body is implementing a counter-cyclical adjustment mechanism for fund product approvals to better protect investor interests, emphasizing a cautious approach towards new equity fund approvals amid high valuation benchmarks [1][2][6]. Group 1: Regulatory Actions - The approval process for new equity funds has become more stringent, with requirements for performance benchmarks to be below the 90th percentile for the last five years and the 80th percentile for the last three months [2][3]. - The regulatory framework encourages fund companies to focus on quality over size, promoting a rational and restrained approach during market highs and increasing counter-cyclical investments during market lows [2][6]. Group 2: Market Trends - Despite a bullish A-share market, fund companies are limiting the scale of new equity fund launches, with many setting initial fundraising caps at 2 billion to 3 billion yuan [1][4]. - A significant portion of newly established equity funds this year has set fundraising limits, with 57% of these caps below 3 billion yuan [5]. Group 3: Fund Management Practices - Fund companies are actively controlling the scale of new products and limiting large subscriptions for existing high-performing funds to protect investor interests and maintain stable fund operations [5][6]. - The focus is on aligning fund size with strategy capacity to avoid increased transaction costs and ensure a fair investment experience for all investors [5]. Group 4: Long-term Investment Ecosystem - The deepening implementation of the counter-cyclical adjustment mechanism is shifting the public fund industry from a focus on scale to one on quality, which is expected to attract more long-term capital and enhance investor satisfaction [7]. - Regulatory measures are designed to create a balanced approval rhythm that avoids excessive capital inflow into popular sectors while supporting key areas like hard technology during market corrections [7].